The American Cancer Society announced the formation of roundtables devoted to breast and cervical cancers to promote and support advancements in both fields.
A patient advocate addresses the potential risks of delaying a cancer screening test. (AACR Cancer Research Catalyst)
Adding the MEK inhibitor selumetinib (Koselugo) to radioactive iodine (RAI) failed to improve the rate of complete response in RAI-refractory thyroid cancer. (Journal of Clinical Oncology)
An integrated approach to colorectal cancer screening within routine clinical practice eliminated racial disparities in death rates for the disease. (Kaiser Permanente, New England Journal of Medicine)
AstraZeneca and Daiichi Sankyo announced that trastuzumab deruxtecan (Enhertu) significantly improved overall survival and progression-free survival in a phase III trial of patients with unresectable/metastatic HER2-low breast cancer, building on results of an earlier study.
A vegetarian diet was associated with a 14% lower risk of developing cancer. (The Guardian)
A large study from Denmark showed that late recurrence in breast cancer is associated with less aggressive disease that has a more favorable prognosis as compared with early recurrence. (Journal of Clinical Oncology)
Enrollment in lung cancer clinical trials decreased by 14% during the height of the COVID-19 pandemic. (International Association for the Study of Lung Cancer)
A new guideline for managing hepatocellular carcinoma, the most common type of liver cancer, emphasizes communication and collaboration within a multidisciplinary team to take advantage of recent treatment advances and provide patients with optimal care. (American Gastroenterological Association)
A new app uses artificial intelligence to filter millions of social media conversations to determine what patients really think about the drugs they take. (Fierce Pharma)
The FDA authorized the first condom developed specifically for anal sex. (Gizmodo)
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.